CFDE Data Portal | Search POLR3F

	Label	Description
	POLR3F associations Collection (Entity type)	Associations for POLR3F_associations
	POLR3F associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	POLR3F Gene (Entity type)	ENSG00000132664 - RNA polymerase III subunit F
	GSE195663 cisplatin 7 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE148200 0 V 2 GEMCITABINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE159678 4 V 2 CHLOROQUINE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE114492 GSE153671 KMT2D inhibition 10 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE125782 3 V 1 GLUTAMINE MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE230634 PARP inhibition 0 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 4 v 9 human dn Gene Set (Entity type)	A Gene Set from LINCS

POLR3F associations

Associations for POLR3F_associations

POLR3F associations.tsv

A file from IDG as part of the Harmonizome project

POLR3F

ENSG00000132664 - RNA polymerase III subunit F

GSE195663 cisplatin 7 v 1 human dn

A Gene Set from LINCS

GSE148200 0 V 2 GEMCITABINE HUMAN UP

A Gene Set from LINCS

GSE159678 4 V 2 CHLOROQUINE HUMAN UP

A Gene Set from LINCS

GSE114492 GSE153671 KMT2D inhibition 10 v 7 human dn

A Gene Set from LINCS

GSE125782 3 V 1 GLUTAMINE MOUSE UP

A Gene Set from LINCS

GSE230634 PARP inhibition 0 v 4 human dn

A Gene Set from LINCS

GSE239844 crizotinib 4 v 9 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.